港股健倍苗苗(02161)6日大涨6.72%,盘中最高升逾8%,创2023年4月以来新高1.29港元。引发该股大涨的主要原因是公司预期截至9月底中期股东应占溢利将同比增长超过50%。
健倍苗苗是一家主营品牌中药及非处方药的知名企业。公司近日发布盈喜,预计其核心品牌的强劲增长是本次业绩表现亮眼的主因。其中,品牌药分部旗下的何济公产品线以及品牌中药分部的保济丸销售势头强劲,带动整体收入和利润显著增长。此外,公司的浓缩中药颗粒业务持续高速增长也为业绩提供了重要支撑。
由于健倍苗苗此前股价一度回落至低位,本次业绩预喜释放出的利好预期引发获利盘青睐,成为推升股价的主要动力。分析人士指出,健倍苗苗中期财报确认业绩大幅增长有望进一步催化股价上行。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.